Longaeva Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.84M Buy
+51,460
New +$3.79M 0.08% 202

Other funds holding KNSA

Longaeva Partners's KNSA Position: Q3 2026 in Review

Longaeva Partners opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 51,460 shares worth $3.84M. The stake represents 0.08% of the portfolio and ranks #202 among its holdings.

305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.

  • Longaeva Partners held 51,460 shares of Kiniksa Pharmaceuticals worth $3.84M as of Q3 2026.
  • Kiniksa Pharmaceuticals was a new Longaeva Partners position in Q3 2026.
  • Kiniksa Pharmaceuticals made up 0.08% of Longaeva Partners's portfolio in Q3 2026, its #202 holding.
  • 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.